characteristics.text: SAMN00149527
characteristics.characteristic: External Id
characteristics.text: University of Toronto
characteristics.characteristic: INSDC center name
characteristics.text: 2010-12-20T10:14:51.450Z
characteristics.characteristic: INSDC first public
characteristics.text: 2014-02-24T17:54:04.912Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS150310
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS150310
characteristics.characteristic: SRA accession
characteristics.text: anti-pol II
characteristics.characteristic: antibody
characteristics.text: 4H8
characteristics.characteristic: antibody name
characteristics.text: Abcam
characteristics.characteristic: antibody vendor
characteristics.text: Jurkat
characteristics.ontologyTerms: http://www.ebi.ac.uk/efo/EFO_0002796
characteristics.characteristic: cell line
characteristics.text: T lymphoma cells
characteristics.characteristic: cell type
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Jurkat T lymphoma cells with 25 ug/ml DRB treatment, pol II ChIP
characteristics.characteristic: source_name
characteristics.text: 25 ug/ml DRB-treated Jurkat cells, ChIP-Seq
characteristics.characteristic: title
characteristics.text: 5,6-dichloro-1-β-D-ribofuranosyl-benzimidazole (DRB)
characteristics.characteristic: treatment